Continuous cytokine exposure of colonic epithelial cells induces DNA damage

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 3, 2005, Pages 363-369

  Seidelin, Jakob B ^a   Nielsen, Ole Haagen ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Apoptosis; Cytokines; DNA damage; HT29 cells; Inflammation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYTOKINE; DICHLORODIHYDROFLUORESCEIN DIACETATE; GAMMA INTERFERON; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHRONIC INFLAMMATION; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; ENTERITIS; EPITHELIUM CELL; FLUORESCENCE MICROSCOPY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ANTINEOPLASTIC AGENTS; CELL DEATH; COLON; COLONIC NEOPLASMS; CYTOKINES; DNA; DNA DAMAGE; ENZYME INHIBITORS; EPITHELIAL CELLS; HT29 CELLS; HUMANS; INTERFERON TYPE II; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OMEGA-N-METHYLARGININE; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 15744378607     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200503000-00017     Document Type: Article

References (32)

1. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000; 51:289-298.
2. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48:526-535.
3. Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. Molecular biology of colorectal cancer. Curr Probl Cancer 1997; 21:233-300.
4. Serafini EP, Kirk AP, Chambers TJ. Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut 1981; 22:648-652.
5. Meinen CD, Noffsinger AE, Belli J, Straughen J, Fischer J, Groden J, et al. Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation. Genes Chromosomes Cancer 1997; 19:170-175.
6. Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996; 56:1237-1240.
7. Lang SM, Stratakis DF, Heinzlmann M, Heldwein W, Wiebecke B, Loeschke K. Molecular screening of patients with long standing extensive ulcerative colitis: detection of p53 and Ki-ras mutations by single strand conformation polymorphism analysis and differential hybridisation in colonic lavage fluid. Gut 1999; 44:822-825.
8. Holzmann K, Weis-Klemm M, Klump B, Hsieh CJ, Borchard F, Gregor M, et al. Comparison of flow cytometry and histology with mutational screening for p53 and Ki-ras mutations in surveillance of patients with long-standing ulcerative colitis. Scand J Gastroenterol 2001; 36:1320-1326.
9. Cawkwell L, Sutherland F, Murgatroyd H, Jarvis P, Gray S, Cross D, et al. Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers. Gut 2000; 46:367-369.
10. Noffsinger AE, Belli JM, Fogt F, Fischer J, Goldman H, Fenoglio-Preiser CM. A germline hMSH2 alteration is unrelated to colonic microsatellite instability in patients with ulcerative colitis. Hum Pathol 1999; 30:8-12.
11. Lundberg JO, Hellstrom PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994; 344:1673-1674.
12. Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111:871-885.
13. Salzman AL, Eaves-Pyles T, Linn SC, Denenberg AG, Szabo C. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 1998; 114:93-102.
14. Linn SC, Morelli PJ, Edry I, Cottongim SE, Szabo C, Salzman AL. Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line. Am J Physiol 1997; 272:G1499-G1508.
15. Kubes P. Inducible nitric oxide synthase: a little bit of good in all of us. Gut 2000; 47:6-9.
16. Tamir S, Tannenbaum SR. The role of nitric oxide (NO) in the carcinogenic process. Biochim Biophys Acta 1996; 1288:F31-F36.
17. Walworth NC. Cell-cycle checkpoint kinases: checking in on the cell cycle. Curr Opin Cell Biol 2000; 12:697-704.
18. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357:593-615.
19. Ryan BM, Russel MG, Langholz E, Stockbrugger RW. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow. Am J Gastroenterol 2003; 98:1682-1687.
20. Green LM, Reade JL, Ware CF. Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods 1984; 70:257-268.
21. Konorev EA, Kennedy MC, Kalyanaraman B. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates. Arch Biochem Biophys 1999; 368:421-428.
22. Ubezio P, Civoli F. Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells. Free Radical Biol Med 1994; 16:509-516.
23. Ostling O, Johanson KJ. Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 1984; 30:291-298.
24. Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988; 115:61-69.
25. Masuda H, Iwai S, Tanaka T, Hayakawa S. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase. J Clin Lab Immunol 1995; 46:111-123.
26. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 2000; 60:184-190.
27. Fleisher AS, Esteller M, Harpaz N, Leytin A, Rashid A, Xu Y, et al. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res 2000; 60:4864-4868.
28. Seidelin JB, Jaattela M, Nielsen OH. Continuous interferon-gamma or tumor necrosis factor-alpha exposure of enterocytes attenuates cell death responses. Cytokine 2004; 27:113-119.
29. Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR, Gores GJ. Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology 2001; 120:190-199.
30. Furuta S, Goto H, Niwa Y, Ohmiya N, Kamiya K, Oguri A, et al. Interferon-gamma regulates apoptosis by releasing soluble tumor necrosis factor receptors in a gastric epithelial cell line. J Gastroenterol Hepatol 2002; 17:1283-1290.
31. Fish SM, Proujansky R, Reenstra WW. Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function. Gut 1999; 45:191-198.
32. Seidelin JB, Nielsen OH, Jaattela M. FAS (CD95/APO-1) induced apoptosis is attenuated in colonic epithelial cells of ulcerative colitis and a colonic cell-line (HT29) exposed to long-term cytokine stimulation. Gastroenterology 2002; 122:A277.